Celladon Files For IPO
socalTECH
OCTOBER 14, 2013
San Diego-based Celladon , a clinical stage biopharmaceuticals firm which is developing enzymes to address calcium regulation, has filed for an IPO. The company said it is looking to raise up to $86.25M in an offering on the NASDAQ Global Market, trading under the symbol CLDN. The company''s IPO is being underwritten by J.P.
Let's personalize your content